IMMUNOME INC (IMNM) Forecast, Price Target & Analyst Ratings

NASDAQ:IMNM • US45257U1088

Current stock price

20.75 USD
+0.74 (+3.7%)
At close:
20.75 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IMMUNOME INC (IMNM).

Forecast Snapshot

Consensus Price Target

Price Target
$35.62
+ 71.64% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.57
Revenue Estimate
255K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$35.62
Upside
+ 71.64%
From current price of $20.75 to mean target of $35.62, Based on 20 analyst forecasts
Low
$26.26
Median
$34.68
High
$42.00

Price Target Revisions

1 Month
1.34%
3 Months
36.04%

Price Target Summary

20 Wall Street analysts provided a forecast for the next 12 months for IMNM. The average price target is 35.62 USD. This implies a price increase of 71.64% is expected in the next year compared to the current price of 20.75.
The average price target has been revised upward by 36.04% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

IMNM Current Analyst RatingIMNM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

IMNM Historical Analyst RatingsIMNM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
85.00%
IMNM was analyzed by 20 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about IMNM.
In the previous month the buy percentage consensus was at a similar level.
IMNM was analyzed by 20 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-04Stephens & Co.Maintains Overweight -> Overweight
2026-03-04Craig-HallumMaintains Buy -> Buy
2026-02-12HC Wainwright & Co.Initiate Buy
2026-01-15WedbushReiterate Outperform -> Outperform
2025-12-16Lake StreetMaintains Buy -> Buy
2025-12-16GuggenheimMaintains Buy -> Buy
2025-12-16Evercore ISI GroupMaintains Outperform -> Outperform
2025-12-01Truist SecuritiesInitiate Buy
2025-11-17Stephens & Co.Maintains Overweight -> Overweight
2025-09-22Goldman SachsInitiate Buy
2025-09-05Craig-HallumInitiate Buy
2025-08-25GuggenheimReiterate Buy -> Buy
2025-08-22Evercore ISI GroupInitiate Outperform
2025-08-07JP MorganMaintains Overweight -> Overweight
2025-04-02Lake StreetInitiate Buy
2025-03-20GuggenheimMaintains Buy -> Buy
2025-03-20Stephens & Co.Reiterate Overweight -> Overweight
2025-03-20WedbushReiterate Outperform -> Outperform
2025-03-11LifeSci CapitalInitiate Outperform
2024-11-14Piper SandlerMaintains Overweight -> Overweight
2024-11-08Stephens & Co.Initiate Overweight
2024-10-25WedbushReiterate Outperform -> Outperform
2024-08-13WedbushReiterate Outperform -> Outperform
2024-08-13Piper SandlerMaintains Overweight -> Overweight
2024-05-31Piper SandlerInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.57
Revenue Estimate
255K
Revenue Q2Q
-91.29%
EPS Q2Q
-10.00%
Number of Analysts
15

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
-56.25%
EPS (1 Month)
6.37%
EPS (3 Months)
6.37%

Next Earnings Summary

IMNM is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.57 USD and the consensus revenue estimate is 255.00K USD.
The next earnings revenue estimate has been revised downward by 56.25% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
IMNM revenue by date.IMNM revenue by date.
14.018M9.041M
-35.50%		6.941M
-23.23%		6.539M
-5.79%		80.256M
1,127.34%		232.73M
189.98%		403.19M
73.24%		598.36M
48.41%		932.81M
55.89%		1.201B
28.75%		1.51B
25.73%
EBITDA
YoY % growth
IMNM ebitda by date.IMNM ebitda by date.
-28.271M
22.50%		-151.889M
-437.26%		-211.647M
-39.34%		-268.398M
-26.81%		-251.801M
6.18%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
IMNM ebit by date.IMNM ebit by date.
-28.728M
22.15%		-153.456M
-434.17%		-214.113M
-39.53%		-283.247M
-32.29%		-270.248M
4.59%		-148.833M
44.93%		27.69M
118.60%		201.38M
627.27%		404.52M
100.87%		609.95M
50.78%		822.75M
34.89%
Operating Margin
IMNM operating margin by date.IMNM operating margin by date.
-204.94%-1,697.33%-3,084.76%-4,331.65%-336.73%-63.95%6.87%33.66%43.37%50.79%54.49%
EPS
YoY % growth
IMNM eps by date.IMNM eps by date.
N/A
67.94%		-5.17
-421.82%		-2.43
53.00%		-2.69
-10.54%		-2.30
14.28%		-1.11
51.86%		0.63
157.05%		2.20
248.39%		3.66
66.20%		4.35
18.73%		5.07
16.54%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.57
-10.00%		-0.62
-24.28%		-0.66
-1.39%		-0.61
19.81%		-0.57
0.14%		-0.55
12.02%		-0.46
30.66%		-0.37
39.75%
Revenue
Q2Q % growth		255K
-91.29%
-100.00%		11.571M
4,437.65%		4.126M13.495M24.803M
EBITDA
Q2Q % growth		-62.257M
-41.41%		-54.5M
-20.49%		-64.218M
-10.15%		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-66.333M
-48.61%		-62.271M
-33.98%		-67.354M
-12.00%		-62.689M
0.27%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

IMNM Yearly Revenue VS EstimatesIMNM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
IMNM Yearly EPS VS EstimatesIMNM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 -4 -6 -8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
15.58%
EPS Next 5 Year
23.79%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
216.45%
Revenue Next 5 Year
141.11%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

IMMUNOME INC / IMNM Forecast FAQ

What is the average price target for IMMUNOME INC (IMNM) stock?

20 analysts have analysed IMNM and the average price target is 35.62 USD. This implies a price increase of 71.64% is expected in the next year compared to the current price of 20.75.

When does IMMUNOME INC (IMNM) report earnings?

IMMUNOME INC (IMNM) will report earnings on 2026-05-11.

What are the consensus estimates for IMNM stock next earnings?

The consensus EPS estimate for the next earnings of IMMUNOME INC (IMNM) is -0.57 USD and the consensus revenue estimate is 255.00K USD.

What is the expected long term growth rate for IMMUNOME INC (IMNM)?

The expected long term growth rate for IMMUNOME INC (IMNM) is 216.45%.